SC 13G/A: CollPlant Biotechnologies Ltd

AI Summary

SC 13G/A filing by CollPlant Biotechnologies Ltd.

Risk Assessment

Risk Level: low

Filing Documents

• clgna1_21324.htm (SC 13G/A) — 39KB
• 0001085146-24-001211.txt ( ) — 41KB

(a)

ITEM 1(a). NAME OF ISSUER: CollPlant Biotechnologies Ltd.

(b)

ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 4 Oppenheimer St, Weizmann Science Park Rehovot 7670104, Israel

(a)

ITEM 2(a). NAME OF PERSON FILING: Roumell Asset Management, LLC ("RAM") James C. Roumell ("Roumell")

(b)

ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 2 Wisconsin Circle, Suite 700 Chevy Chase, MD 20815

(c)

ITEM 2(c). CITIZENSHIP: Maryland USA

(d)

ITEM 2(d). TITLE OF CLASS OF SECURITIES: Ordinary shares, par value NIS 1.50 per share

(e)

ITEM 2(e). CUSIP NUMBER: M2R51X116 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [X] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [X] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: RAM is a registered investment adviser under the Investment Advisers Act of 1940. Roumell is the President of RAM and holds a controlling percentage of its outstanding voting securities. Roumell is joining in this filing on Schedule 13G pursuant to Rule 13d-1(k)(1). ITEM 4. See Items 5-11 on the cover sheets of this Schedule 13G. (a) Amount beneficially owned: 0 (b) Percent of class: 0% (The denominator is based on the 11,443,023 shares of common stock outstanding as of September 30, 2023, as stated on the facing page of the Form 6-K for the quarter ended September 30, 2023 (the Form 6-K) filed by Issuer.) (c) Number of

View Full Filing

View this SC 13G/A filing on SEC EDGAR